MRVIMaravai LifeSciences Holdings, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +57% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 13% since the previous count, up from 5.9% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MRVI is trading
Maravai LifeSciences Holdings, Inc. is +177% over the past year while the S&P 500 is +18%: 158 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +57%
vs 200-day average · a clear uptrend
- RSI (14)
- 54
RSI (14) · neutral
- Below its 52-week high
- 17%
Below its 52-week high
Details›
- Last close2026-10-09
- $7.47
- 1 monthS&P 500 +2.7%
- +11%
- 1 yearS&P 500 +18%
- +177%
- 5 yearsS&P 500 +88%
- −84%
- vs 50-day average$7.14
- +4.6%
- 52-week high
- $8.99
- 52-week low
- $2.69
- Annualised volatility
- 80%
| Year | Return |
|---|---|
| 2026 (year to date) | +130% |
| 2025 | −40% |
| 2024 | −17% |
| 2023 | −54% |
| 2022 | −66% |
| 2021 | +49% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | −3.7% |
| Feb | 6 | 4 of 6 | +5.6% |
| Mar | 6 | 2 of 6 | −7.5% |
| Apr | 6 | 2 of 6 | +1.8% |
| May | 6 | 4 of 6 | +6.4% |
| Jun | 6 | 3 of 6 | +2.7% |
| Jul | 6 | 3 of 6 | +5.5% |
| Aug | 6 | 3 of 6 | +2.3% |
| Sep | 6 | 3 of 6 | +2.2% |
| Oct | 6 | 1 of 6 | −14% |
| Nov | 5 | 2 of 5 | −7.1% |
| Dec | 6 | 1 of 6 | +0.23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.